Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy
To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields. Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 200...
Saved in:
Published in | Practical radiation oncology |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.09.2021
|
Online Access | Get more information |
Cover
Loading…
Abstract | To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields.
Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 2009 were analyzed for associations with outcomes. Sites of LRR from all patients with available imaging (39) were contoured on computed tomography image sets of patients with representative anatomy, and ART fields were proposed based on these distributions.
A total of 279 patients with a median follow-up of 13.0 years were analyzed. The 5-year cumulative incidence of LRR was 16.7% (95% CI, 12.2-21). Pathologic risk factors (PRFs) associated with increased risk of LRR included tumor in both the renal pelvis and ureter, T stage ≥2, lymph node involvement, grade 3 histology, and positive surgical margins (P < .05). Patients with an increased number of PRFs had a significantly greater risk of LRR. The 5-year cumulative incidence estimates of LRR were 5.3% (95% CI, 1.8%-16.0%), 15.6% (95% CI, 9.5%-25.7%), and 43.9% (95% CI, 31.1%-62.1%) for those with 1, 2, and ≥3 PRFs, respectively. ART fields covering the renal fossa and retroperitoneal lymph nodes from the superior border of L1 through the aortic bifurcation would encompass all sites of LRR for 33 of 46 patients (72%). Non-LRR bladder and distant failure occurred in 101 (36.2%) and 73 (26.2%) of the patients, respectively. The 5-year cumulative incidence estimate of distant failure was 22.5% (95% CI, 17.4%-27.3%).
In patients receiving nephroureterectomy for UTUC, LRR is significantly increased in patients with 2 or more PRFs. These data provide clinically valuable insight into the selection of candidates for ART and the design of ART fields. |
---|---|
AbstractList | To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose adjuvant radiation therapy (ART) fields.
Clinical and pathologic variables for patients receiving nephroureterectomy for UTUC between 1995 and 2009 were analyzed for associations with outcomes. Sites of LRR from all patients with available imaging (39) were contoured on computed tomography image sets of patients with representative anatomy, and ART fields were proposed based on these distributions.
A total of 279 patients with a median follow-up of 13.0 years were analyzed. The 5-year cumulative incidence of LRR was 16.7% (95% CI, 12.2-21). Pathologic risk factors (PRFs) associated with increased risk of LRR included tumor in both the renal pelvis and ureter, T stage ≥2, lymph node involvement, grade 3 histology, and positive surgical margins (P < .05). Patients with an increased number of PRFs had a significantly greater risk of LRR. The 5-year cumulative incidence estimates of LRR were 5.3% (95% CI, 1.8%-16.0%), 15.6% (95% CI, 9.5%-25.7%), and 43.9% (95% CI, 31.1%-62.1%) for those with 1, 2, and ≥3 PRFs, respectively. ART fields covering the renal fossa and retroperitoneal lymph nodes from the superior border of L1 through the aortic bifurcation would encompass all sites of LRR for 33 of 46 patients (72%). Non-LRR bladder and distant failure occurred in 101 (36.2%) and 73 (26.2%) of the patients, respectively. The 5-year cumulative incidence estimate of distant failure was 22.5% (95% CI, 17.4%-27.3%).
In patients receiving nephroureterectomy for UTUC, LRR is significantly increased in patients with 2 or more PRFs. These data provide clinically valuable insight into the selection of candidates for ART and the design of ART fields. |
Author | Potretzke, Aaron M Choo, Richard Pisansky, Thomas M Gao, Robert W Harmsen, W Scott Tollefson, Matthew K Stish, Bradley J Davis, Brian J Thompson, R Houston Quevedo, Fernando J |
Author_xml | – sequence: 1 givenname: Robert W surname: Gao fullname: Gao, Robert W organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota – sequence: 2 givenname: Matthew K surname: Tollefson fullname: Tollefson, Matthew K organization: Department of Urology, Mayo Clinic, Rochester, Minnesota – sequence: 3 givenname: R Houston surname: Thompson fullname: Thompson, R Houston organization: Department of Urology, Mayo Clinic, Rochester, Minnesota – sequence: 4 givenname: Aaron M surname: Potretzke fullname: Potretzke, Aaron M organization: Department of Urology, Mayo Clinic, Rochester, Minnesota – sequence: 5 givenname: Fernando J surname: Quevedo fullname: Quevedo, Fernando J organization: Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota – sequence: 6 givenname: Richard surname: Choo fullname: Choo, Richard organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota – sequence: 7 givenname: Brian J surname: Davis fullname: Davis, Brian J organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota – sequence: 8 givenname: Thomas M surname: Pisansky fullname: Pisansky, Thomas M organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota – sequence: 9 givenname: W Scott surname: Harmsen fullname: Harmsen, W Scott organization: Department of Biostatistics & Information, Mayo Clinic, Rochester, Minnesota – sequence: 10 givenname: Bradley J surname: Stish fullname: Stish, Bradley J email: stish.bradley@mayo.edu organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: stish.bradley@mayo.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33636378$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kN1Kw0AQhRdR_Km-gBeyL5C42fxflmpVKFpKi5dlujtptiS7YbIt9JV8SlOqzMXAnMP5hnPHLq2zyNhjJMJIRNnzLuyIXCiFjEIhQyHSC3YbFXkZFGlUXrObOM6GyYtb9jMn1EZ5Rz13FZ855Qi3xllo-ALVngitQg5W8xdsjEXwg3iyjvVufwDr-QK0OV-XNRJ0Rz412OieV474fFDQ-p5_G1_zVdch8SWB8nxFztdD5ACaACljXQsnJJqDsVv-iV1Nbk_okXD4rz3es6sKmh4f_vaIraavy8l7MPt6-5iMZ4GK08wHicohAdgolemikLkUCeiNznModRwVhcYyk6mUmzwWSVnFotSolEgLQMiSJJIj9nTO7fabFvW6I9MCHdf_pclfggBx0Q |
CitedBy_id | crossref_primary_10_4103_UROS_UROS_58_22 crossref_primary_10_1016_j_purol_2022_08_003 |
ContentType | Journal Article |
Copyright | Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved. |
DBID | NPM |
DOI | 10.1016/j.prro.2021.02.005 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1879-8519 |
ExternalDocumentID | 33636378 |
Genre | Journal Article |
GroupedDBID | NPM |
ID | FETCH-LOGICAL-c356t-4c7a4aabcc6d8827204adbd77a9d3188de962522b73049f309decc058aea64412 |
IngestDate | Wed Jun 21 02:24:41 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | Copyright © 2021 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c356t-4c7a4aabcc6d8827204adbd77a9d3188de962522b73049f309decc058aea64412 |
PMID | 33636378 |
ParticipantIDs | pubmed_primary_33636378 |
PublicationCentury | 2000 |
PublicationDate | 2021-09-01 |
PublicationDateYYYYMMDD | 2021-09-01 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Practical radiation oncology |
PublicationTitleAlternate | Pract Radiat Oncol |
PublicationYear | 2021 |
Score | 2.2778645 |
Snippet | To identify factors predictive of locoregional recurrence (LRR) in upper tract urothelial carcinoma (UTUC) treated with nephroureterectomy and to propose... |
SourceID | pubmed |
SourceType | Index Database |
Title | Predictors of Locoregional Recurrence and Delineation of Adjuvant Radiation Therapy Fields for Patients With Upper Tract Urothelial Carcinoma Receiving Nephroureterectomy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33636378 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitswEBXZFsq-lJbeb8xD34xLfJX1GJZuQyFhWRK6b4tkyWWXxjbGedlP6i_05zoj-bbptrQlYIJkR8FzkEZHM2cYe88TVczjQPkhF9KPVWp8GYbKF5qrpAiCIrPyxat1utzGny-Si9nsxyRqad-qD_nNnXkl_2NVbEO7UpbsP1h2-FFswO9oX7yihfH6VzY-a-iYxdbLIaq_IknKr47bOyce3SnIumBjcicH93Chr_foQrfeOUkT2NaNkxfwTimkzYo0kHz_lU2A-0Jk7bauTUNi6HnrbRtK3PpGbPsJFSMqq52kIc2V5SfWpqbyPw2F2tCpwO7W2bGTSCJsNMPoVZnf4vc_yWqM-_YGHmhDNEfRJYl1pcpHonYMbsEnvWW1J8d2mPurFv_PjYtFWsgGB11NKY8wGGK6cMVy03TGhY--orhzEXB8xDUuQQ2ld4adKmsyvRkNWe8sLKIoxY-rI_Tn3gNh7r7riB3xjKbY9dmqS8tyEYSH4x-zB_0zB5sY68xsHrGH3S4EFg5Sj9nMlE_Y9xFOUBUwhROMcAKEE0zgRLf2cIIBTtDBCRycAOEEPZyA4AQWTmDhBCOcYIATDHCCX-H0lG1PP25Oln5XysPPoyRt_TjnMpZS5XmqcU9HlZGkVppzKTSuKpk2AjfiOElwOvYtornQOLfMk0waSR57-IzdK6vSvGAQhCrNlZFZqpK4CKIs4SYzIteZFIUJxEv23L3ay9rptVz2L_3Vb3tes-MRZ2_Y_QInCPMWvc1WvbN2_QkMHIx4 |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+Locoregional+Recurrence+and+Delineation+of+Adjuvant+Radiation+Therapy+Fields+for+Patients+With+Upper+Tract+Urothelial+Carcinoma+Receiving+Nephroureterectomy&rft.jtitle=Practical+radiation+oncology&rft.au=Gao%2C+Robert+W&rft.au=Tollefson%2C+Matthew+K&rft.au=Thompson%2C+R+Houston&rft.au=Potretzke%2C+Aaron+M&rft.date=2021-09-01&rft.eissn=1879-8519&rft_id=info:doi/10.1016%2Fj.prro.2021.02.005&rft_id=info%3Apmid%2F33636378&rft_id=info%3Apmid%2F33636378&rft.externalDocID=33636378 |